The update knowledge on myocarditis from the JCS 2023 Guideline for the Diagnosis and Treatment of Myocarditis
-
摘要: 日本循环学会于2023年3月发布了《2023JCS心肌炎诊断和治疗指南》,结合近年研究进展,对心肌炎分类、诊断、预后、治疗以及特殊类型心肌炎等内容进行更新。本文就2023JCS指南的部分要点进行提炼和解读,以期为我国临床医生管理心肌炎患者提供一定的实践指导。Abstract: In March 2023, the Japanese Circulation Society(JCS) published the "JCS 2023 Guideline on the diagnosis and treatment of myocarditis", which updates the classification, diagnosis, prognosis, treatment, and special types of myocarditis based on recent research progress. This article summarizes and interprets some key points of the 2023JCS guidelines, in order to provide practical guidance for clinicians in China to manage patients with myocarditis.
-
[1] Lynge TH, Nielsen TS, Gregers Winkel B, et al. Sudden cardiac death caused by myocarditis in persons aged 1-49 years: a nationwide study of 14 294 deaths in Denmark[J]. Forensic Sci Res, 2019, 4(3): 247-256. doi: 10.1080/20961790.2019.1595352
[2] Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review[J]. JAMA, 2023, 329(13): 1098-1113. doi: 10.1001/jama.2023.3371
[3] Vaduganathan M, Mensah GA, Turco JV, et al. The global burden of cardiovascular diseases and risk: a compass for future health[J]. J Am Coll Cardiol, 2022, 80(25): 2361-2371. doi: 10.1016/j.jacc.2022.11.005
[4] Kociol RD, Cooper LT, Fang JC, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the american heart association[J]. Circulation, 2020, 141(6): e69-e92.
[5] Ammirati E, Frigerio M, Adler ED, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document[J]. Circ Heart Fail, 2020, 13(11): e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405
[6] Nagai T, Inomata T, Kohno T, et al. JCS 2023 Guideline on the diagnosis and treatment of myocarditis[J]. Circ J, 2023, 87(5): 674-754.
[7] Luetkens JA, Faron A, Isaak A, et al. Comparison of original and 2018 lake louise criteria for diagnosis of acute myocarditis: results of a validation cohort[J]. Radiol Cardiothorac Imaging, 2019, 1(3): e190010. doi: 10.1148/ryct.2019190010
[8] Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery[J]. J Am Coll Cardiol, 2012, 59(18): 1604-1615. doi: 10.1016/j.jacc.2012.01.007
[9] Li JH, Xu XQ, Zhu YJ, et al. Subendocardial Involvement as an Underrecognized Cardiac MRI Phenotype in Myocarditis[J]. Radiology, 2022, 302(1): 61-69. doi: 10.1148/radiol.2021211276
[10] Shields RC, Tazelaar HD, Berry GJ, et al. The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis[J]. J Card Fail, 2002, 8(2): 74-78. doi: 10.1054/jcaf.2002.32196
[11] Singh V, Mendirichaga R, Savani GT, et al. Comparison of utilization trends, indications, and complications of endomyocardial biopsy in native versus donor hearts(from the Nationwide Inpatient Sample 2002 to 2014)[J]. Am J Cardiol, 2018, 121(3): 356-363. doi: 10.1016/j.amjcard.2017.10.021
[12] Bennett MK, Gilotra NA, Harrington C, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009[J]. Circ Heart Fail, 2013, 6(4): 676-684.
[13] Ammirati E, Cipriani M, Moro C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter lombardy registry[J]. Circulation, 2018, 138(11): 1088-1099.
[14] Wang ZH, Liao YH, Yuan J, et al. Continued elevation of plasma IL-4 and IL-17 predicts the progression from VMC to DCM[J]. Dis Markers, 2020, 2020: 9385472.